Erk5 degraders and uses thereof
Номер патента: EP4405338A1
Опубликовано: 31-07-2024
Автор(ы): Eric Wang, Inchul YOU, Nathanael S. Gray
Принадлежит: Dana Farber Cancer Institute Inc
Опубликовано: 31-07-2024
Автор(ы): Eric Wang, Inchul YOU, Nathanael S. Gray
Принадлежит: Dana Farber Cancer Institute Inc
Реферат: Described are the bifunctional compounds, compositions and methods of treating a disease or disorder characterized by aberrant extracellular-signal-regulated kinase 5 (ERK5) activity.
Selective histone deacetylase 8 (hdac8) degraders and methods of use thereof
Номер патента: WO2024006403A3. Автор: YUAN Xiong,Eric S. FISCHER,Katherine A. DONOVAN. Владелец: Dana-Farber Cancer Institute, Inc.. Дата публикации: 2024-06-13.